SYMPATH Symposium on Targeting Synucleinopathies

The SYMPATH Symposium on Targeting Synucleinopathies will bring together world-leading experts from Europe and the US to discuss recent progress in developing therapeutic vaccinations targeting Parkinson's disease (PD) and Multiple System Atrophy (MSA). The agenda includes pathogenesis, biomarkers and clinical challenges in Parkinson’s.

SYMPATH is an EU-funded project within the seventh framework programme.
http://www.sympath-project.eu/

Confirmed Speakers include
• Omar El-Agnaf, Hamid Bin Khalifa University, Qatar
• Kuldip Dave, Michael J. Fox Foundation, USA
• Joaquim Ferreira, University of Lisbon
• Gergana Galabova, AFFiRiS AG, Austria
• Kenneth Marek, Yale University, USA
• Wassilios Meissner, University Hospital Bordeaux, France
• Werner Poewe, Medical University Innsbruck, Austria
• Dieter Volc, Prosenex Ambulatorium BetriebsgesmbH, Austria
• Dieter Willbold, Forschungszentrum Jülich GmbH, Germany

Venue: IMBA/GMI Lecture Hall, Institute of Molecular Biotechnology, Dr. Bohr-Gasse 3, A-1030, Vienna, Austria